Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
Abstract Current therapeutic approaches to depression fail for millions of patients due to lag in clinical response and non-adherence. Here we provide new support for the antidepressant effect of an anesthetic drug, ketamine, by Inverse-Frequency Analysis of eight million reports from the FDA Advers...
Guardado en:
Autores principales: | Isaac V. Cohen, Tigran Makunts, Rabia Atayee, Ruben Abagyan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29cfb95bdea44b70a57ebcd61bd9f670 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Publisher Correction: Population scale data reveals the antidepressant effects of ketamine and other therapeutics approved for non-psychiatric indications
por: Isaac V. Cohen, et al.
Publicado: (2017) -
Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency
por: Naghmeh Nikkheslat
Publicado: (2021) -
Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database
por: Isaac V. Cohen, et al.
Publicado: (2021) -
Immunoregulation and antidepressant effect of ketamine
por: Zhang Nan, et al.
Publicado: (2021) -
The role of dissociation in ketamine’s antidepressant effects
por: Elizabeth D. Ballard, et al.
Publicado: (2020)